Trulieve Cannabis: Government May Finally Come To The Rescue
- Trulieve Cannabis stock soared 62% following the potential rescheduling of cannabis from a Schedule 1 controlled substance to a Schedule 3 drug.
- If cannabis is reclassified, Trulieve and other MSOs could potentially drop the 280E taxes and uplist to U.S. stock exchanges.
- Trulieve Cannabis could see a surge in free cash flow levels, greatly enhancing its capital position.
- TCNNF stock is cheap at only 3x the current adjusted EBITDA.